Online auction on behalf of Novartis

Published: 25-May-2018
Manufacturing

Featuring lab equipment such as UHPLCs, Gas Chromatographs, HPLCs, Mass Spectrometers and much more

EquipNet is a comprehensive surplus asset management company. EquipNet appraise, broker and auction laboratory instrumentation and manufacturing equipment.

01-31 May 2018

Bidding starts: 30th April, 09:00 AM CET

Lots begin closing: 31st May, 14:00 CET

Click here to register

  • Companies:
  • EquipNet
  • Novartis
See more

You may also like

Manufacturing

Unither Pharmaceuticals acquires Novartis' Brazilian manufacturing facility

Read more
Unither has acquired Novartis' Brazilian plant São Paulo, Brazil, in order to enlarge its reach on multidose ophthalmic containers, benefitting from the sterile operations facility

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Unither Pharmaceuticals acquires Novartis' Brazilian manufacturing facility

Unither has acquired Novartis' Brazilian plant São Paulo, Brazil, in order to enlarge its reach on multidose ophthalmic containers, benefitting from the sterile operations facility
Manufacturing

Novartis completes acquisition of precision medicine developer Chinook

Novartis has announced the acquisition of a US-based biopharmaceutical company focused on the discovery of precision medicines for kidney diseases named Chinook Therapeutics
Manufacturing

MIT researchers to lead a new centre for continuous mRNA manufacturing

Faculty at the MIT are embarking upon a three-year research programme to design the world's first fully integrated, continuous mRNA manufacturing platform
Manufacturing

Sterling acquires API manufacturing facility

The facility will provide additional capacity for Sterling’s growing API manufacturing services
Manufacturing

Gain immediate financial return for your surplus equipment

Maximise your company's financial return and focus on your sustainability initiatives by selling your used equipment on EquipNet.com.
Manufacturing

EquipNet enhances their Equipment Sustainability Programmes

This comprehensive software ensures not just cost savings but also enables waste to be diverted from landfill
Manufacturing

Sterling Pharma Solutions acquires Novartis Facility in Ireland

The announcement follows several investments in the CDMO’s manufacturing capabilities in 2021, as well as acquisitions in the US and UK
Subscribe now